According to our new research study on " mHealth Market Forecast to 2028 – COVID-19 Impact and Analysis – by Service, Devices, and End User," the market is expected to reach US$ 410.39 billion by 2028 from US$ 70.83 billion in 2021; it is estimated to grow at a CAGR of 28.5% from 2021 to 2028. The report highlights trends prevailing in the market and factors governing its growth. The increasing adoption of smartphones and other mobile platforms, and the exponential spread of COVID-19 contribute to the market progress. Further, growing awareness regarding mHealth and rising government funding for the development and adoption of virtual medical platforms are likely to foster the mHealth market growth during the forecast period. However, security and privacy issues restrict the market growth.
Download PDF Sample Copy at:
Impact of COVID-19 Pandemic on MHealth Market
The COVID-19 pandemic has adversely affected as the manufacturing and healthcare, sectors, among others. Various drug manufacturers have started developing vaccines against COVID-19, which has suppressed the production levels of vaccines for other preventable diseases. On the other hand, the pandemic has offered vital growth opportunities for the mHealth market growth. The FDA has increased its efforts to support the health of people and has imposed several guidelines for hospitals and medical device companies. With the surge in importance of mHealth apps in the aftermath of the COVID-19 pandemic, national health authorities of different countries are expected to launch rating and licensing platforms for higher efficiency and reduce mass gathering. For instance, the United Kingdom National Health Service (NHS) has expanded its publicly funded prescribing platform to include clinically safe consumer apps. Various companies also enhanced their research and development activities for telemedicine and mHealth. For instance, companies such as MediBuddy, Practo, Wysa, HealthifyMe, Qikwell Technologies, icliniq, and Emunocare are the startups focusing on COVID-19-related services. Further, Thermo Fisher Scientific has increased its production of vaccines, and the company produced 5 million test kits per week in April 2020. Likewise, Abbott has received Emergency Use Authorization (EUA) for a point-of-care test that can provide results in minutes.
Allscripts Healthcare LLC, Koninklijke Philips N.V., Medtronic, Boston Scientific Corp., athenaheath Inc., Honeywell Life Care Solutions, Cisco Systems Inc., Omron Corp., Masimo, and AgaMatrix Inc. are among the leading companies operating in the mHealth market.
Regional Analysis
The report offers in-depth assessment of the growth and other aspects of the mHealth Market in important regions. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2028. These analyses will help the reader to understand the potential worth of investment in a particular region.
About The Insight Partners:
The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Manufacturing and Construction, Technology, Chemicals and Materials.
We offer our clients multiple ways to customize research as per their specific needs and budget.
Contact us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
